Spots Global Cancer Trial Database for A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Official Title: A Phase III Randomized, Controlled, Multicenter, Open-label Study of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Study ID: NCT04939142
Conditions
Study Description
Brief Summary: This is a Phase III Randomized, Controlled, Multicenter, Open-label Study of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM).
Detailed Description: This is a Phase III Randomized, Controlled, Multicenter, Open-label Study of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM). About 150 subjects are planned to be enrolled in this study, and be randomized into two treatment Arms in a 2:1 allocation (SVd Arm or Vd Arm).
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
The First Affiliated Hospital OF USTC, Hefei, Anhui, China
The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China
Beijing Chao-Yang Hospital, Beijing, Beijing, China
Peking University People'S Hospital, Beijing, Beijing, China
Xinqiao Hospital Army Medical University, Chongqing, Chongqing, China
Guangdong Provincial People'S Hospital, Guangzhou, Guangdong, China
Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
Nanfang Hospital, Guangzhou, Guangdong, China
Shenzhen Second People'S Hospital, Shenzhen, Guangdong, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan, Hubei, China
Xiangya Hospital Central South University, Changsha, Hunan, China
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Affiliated Hospital of Nantong University, Nanchang, Jiangxi, China
The First Hospital of Nanchang, Nanchang, Jiangxi, China
Shengjing Hospital China Medical University, Shenyang, Liaoning, China
Shandong Provincial Hospital, Jinan, Shandong, China
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Qingdao Municipal Hospital, Qingdao, Shandong, China
Qilu Hospital of Shangdong University, Jinan, Shangdong, China
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
Shanghai Sixth People's Hospital Affiliated to Shanghai JiaoTong University, Shanghai, Shanghai, China
Sichuan Provincial People's Hospital, Chengdu, Sichuan, China
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
Sir Run Run Shaw Hospital Zhejiang University of Medicine, Hangzhou, Zhejiang, China
The First Affiliated Hospital, Zhejiang University School of Medicine, Hanzhou, Zhejiang, China
Ningbo First Hospital, Ningbo, Zhejiang, China
Contact Details
Name: Jin Lu, PhD
Affiliation: Peking University People's Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
